Higher BMI may surprisingly protect against death in critical illness, challenging decades of weight-loss advice. Research reveals complex biological mechanisms where metabolic reserves, mental health, and fitness matter more than the scale.
Peptide therapeutics are redefining drug development by bridging the gap between small molecules and biologics, offering precision targeting with better tissue penetration. Recent FDA approvals, advanced design techniques like stapling and cyclization, and a projected market growth to $81.5 billion by 2034 signal their expanding role in treating cancer, metabolic diseases, and rare conditions.
Loading featured articles...